Lack of adverse clopidogrel-atorvastatin clinical interaction from ing dose regimen of clopidogrel - Saw, J; Steinhubl, SR; Berger, PB (Consistently, our study does not suggest that statins metabolized by CYP3A4 (atorvastatin, simvastatin) curtail the beneficial effects of clopidogrel in PCI. Acknowledgements The EXCELSIOR study was supported by an unrestricted grant from Herz- Zentrum Bad Krozingen. The authors appreciate the invaluable technical assistance of Martina Siefer and Petra Enderle from the Laboratory of the Department of Clinical Pharmacology. secondary analysis of a randomized, placebo-controlled clopidogrel trial. Circulation, 2003)
et al.